Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Clin Transplant. 2017 Jun 19;31(8):10.1111/ctr.13011. doi: 10.1111/ctr.13011

TABLE 5.

Multivariable models of the association between race/ethnicity and ABO-nonidentical transplantation

Univariable analysis Multivariable modelsa

Model 1 Model 2 Model 3




sHR (95% CI) P-value sHR(95%CI) P-value sHR(95%CI) P-value sHR(95%CI) P-value
Race/ethnicity

 Non-Hispanic White Ref Ref Ref Ref Ref Ref Ref Ref

 Black 1.61 (1.32–1.98) <.001 1.30 (1.06–1.62) .013 1.30 (1.05–1.61) .016 0.82 (0.65–1.01) .067

 Hispanic 0.91 (0.74–1.13) .40 0.85 (0.68–1.04) .12 0.90 (0.73–1.12) .35 1.05 (0.84–1.31) .67

 Asian 1.54 (1.15–2.05) .003 1.63 (1.18–2.25) .003 1.70 (1.22–2.36) .001 0.72 (0.51–1.03) .074

 Other 1.40 (0.86–2.31) .18 1.28 (0.77–2.12) .34 1.31 (0.79–2.17) .30 1.37 (0.80–2.32) .25

Region

 Low MELD (<28) Ref Ref Ref Ref

 Medium MELD (28–30) 1.07 (0.88–1.30) .51 0.88 (0.72–1.08) .23

 High MELD (>30) 0.83 (0.71–0.98) .025 0.72 (0.61–0.85) <.001

Recipient ABO Status

 O Ref Ref

 A 0.68 (0.52–0.90) .007

 B 11.6 (9.43–14.1) <.001

 AB 29.3 (23.5–36.5) <.001

N=27 324 in each model.

a

Each model is also adjusted for recipient age, sex, etiology of liver disease, exception points granted, initial laboratory Model for End-Stage Liver Disease (MELD) score, and listing center volume.